Amrutanjan Health Care Limited (AMRUTANJAN) AI Stock Analysis

• Market Cap: ₹15.55B
• Dividend Yield: 0.68%
• Average Volume (3M): 587.00
• Price to Earnings (P/E): 24.8
• Beta (1Y): 0.94
• Revenue Growth: 7.36%
• EPS Growth: 19.31%
• Country: IN
• Employees: 634
• Sector: Healthcare
• Sector Strength: 45
• Industry: Drug Manufacturers - Specialty & Generic
• EPS (TTM): 6.73
• Shares Outstanding: 29,230,630
• 10 Day Avg. Volume: 607
• 30 Day Avg. Volume: 587
• PEG Ratio: 2.73
• Price to Book (P/B): 5.70
• Price to Sales (P/S): 4.13
• P/FCF Ratio: 121.26
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): N/A

• Rating: 63 Neutral
• Price Target: ₹527.00 ▼(-21.52% Downside)
• Action: Downgraded Date: 04/01/26
• Date: Action: Downgraded 04/01/26

The score is supported primarily by strong financial health (profitability, low leverage, and liquidity), but is held back by very weak technical momentum (below key moving averages with negative MACD). Valuation is neither clearly attractive nor expensive, with only a modest dividend yield.

Positive Factors

Strong balance sheet

Low leverage and substantial cash reserves give the company durable financial flexibility. This supports continued investment in distribution and marketing, cushions against demand shocks, and reduces refinancing risk — important for multi-quarter stability and optionality in strategic initiatives.

Negative Factors

Inconsistent free cash flow

Volatile free cash flow growth reduces predictability of available cash for dividends, buybacks, or incremental capex. Over multiple quarters this can constrain strategic investments and force reliance on reserves or external funding when cash generation underperforms expectations.

Amrutanjan Health Care Limited Business Overview & Revenue Model

Company Description

Amrutanjan Health Care Limited manufactures, supplies, and sells ayurvedic pain balms, non-alcoholic beverages, and sanitary napkins. The company operates through OTC Products, Beverages, and Others segments. It provides pain management products c...

Read more

Amrutanjan Health Care Limited manufactures, supplies, and sells ayurvedic pain balms, non-alcoholic beverages, and sanitary napkins. The company operates through OTC Products, Beverages, and Others segments. It provides pain management products c...

How the Company Makes Money

Amrutanjan Health Care Limited primarily makes money by manufacturing and selling branded OTC consumer healthcare products. Its core revenue stream comes from sales of pain-management products (notably topical analgesic balms and related pain-reli...

Read more

Amrutanjan Health Care Limited primarily makes money by manufacturing and selling branded OTC consumer healthcare products. Its core revenue stream comes from sales of pain-management products (notably topical analgesic balms and related pain-reli...

Amrutanjan Health Care Limited Financial Statement Overview

Breakdown	TTM	Mar 2025	Mar 2024	Mar 2023	Mar 2022	Mar 2021
Income Statement
Total Revenue	4.70B	4.51B	4.21B	3.80B	4.05B	3.32B
Gross Profit	2.43B	2.46B	1.46B	1.98B	2.25B	1.91B
EBITDA	839.37M	758.79M	681.60M	590.79M	946.99M	861.66M
Net Income	566.96M	508.35M	449.73M	398.35M	671.89M	611.90M
Balance Sheet
Total Assets	4.32B	4.21B	3.67B	3.62B	3.50B	2.74B
Cash, Cash Equivalents and Short-Term Investments	2.07B	1.95B	2.07B	1.93B	2.01B	1.75B
Total Debt	19.32M	20.78M	17.28M	9.09M	8.80M	13.42M
Total Liabilities	902.90M	947.73M	783.82M	713.21M	847.44M	587.06M
Stockholders Equity	3.42B	3.27B	2.88B	2.91B	2.65B	2.16B
Cash Flow
Free Cash Flow	-78.22M	153.46M	211.93M	102.91M	287.32M	878.02M
Operating Cash Flow	109.07M	508.99M	279.11M	192.18M	521.96M	897.63M
Investing Cash Flow	-82.16M	-309.66M	191.65M	-24.75M	-362.12M	-877.61M
Financing Cash Flow	-76.94M	-134.90M	-482.66M	-140.26M	-167.02M	-62.83M

Amrutanjan Health Care Limited Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 671.50
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:AMRUTANJAN, the sentiment is Negative. The current price of 671.5 is above the 20-day moving average (MA) of 525.94, above the 50-day MA of 574.88, and above the 200-day MA of 666.32, indicating a bearish trend. The MACD of -20.88 indicates Negative momentum. The RSI at 36.95 is Neutral, neither overbought nor oversold. The STOCH value of 44.39 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:AMRUTANJAN.

Amrutanjan Health Care Limited Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
TTKHLTCARE	64 Neutral	₹12.59B	34.84	―	0.95%	6.98%	-17.11%
AMRUTANJAN	63 Neutral	₹15.55B	24.83	―	0.68%	7.36%	19.31%
KRSNAA	58 Neutral	₹19.41B	38.37	―	0.38%	11.51%	21.56%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
INDOCO	49 Neutral	₹18.20B	-18.14	―	0.08%	-2.81%	-444.69%
ZOTA	41 Neutral	₹37.12B	-40.91	―	0.06%	82.58%	-63.05%